Drug intelligence / Profile preview

kisspeptin-13

Development stage
Preclinical
Modality
Peptides
Administration
Intraperitoneal, Subcutaneous
01

Overview

Kisspeptin-13 (KP-13) is an endogenous 13-amino-acid peptide derived from the proteolytic cleavage of the KISS1 gene product (prepro-kisspeptin). It acts as a potent agonist of the KiSS-1 receptor (KISS1R, also known as GPR54), which is a Gq/11-coupled receptor. Kisspeptin-13 plays a critical role in the neuroendocrine regulation of the hypothalamic-pituitary-gonadal (HPG) axis, stimulating the release of gonadotropin-releasing hormone (GnRH), which subsequently triggers the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In addition to its reproductive functions, kisspeptin-13 has been investigated in preclinical research for its roles in glucose homeostasis (where it inhibits insulin secretion), memory consolidation (showing neuroprotective effects against amyloid-beta pathology), and idiopathic pulmonary fibrosis.

Other names
KiSS-1 (109-121)KiSS-1 (109-121) (human)KP-13KP13KP 13kisspeptin 13kisspeptin13kisspeptin-13malignant melanoma metastasis-suppressor KiSS-1 (109-121)malignant melanoma metastasis-suppressor KiSS-1 (109-121) (human)metastin (42-54)metastin (42-54) (human)
02

Targets

KISS1R (Kisspeptin receptor)

Beyond the preview

Go deeper on kisspeptin-13.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on kisspeptin-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call